Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05374395 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Enhancing Substance Use Treatment Services to Decrease Dropout and Improve Outpatient Treatment Utilization in Emerging Adults

Study acronym: P2P
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 4, 2026 (before its estimated October 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fieldsv10
  2. Notable Enrollment target: estimated 1750 to confirmed 11v9 Show 4 more changesShow less
    • Primary completion date: Oct 1, 2025 to Oct 1, 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Feb 28, 2026 to Feb 28, 2027
    • Site details revised
  3. Minor Trial status: Enrolling by Invitation to Recruiting
    • Site details revised
    v8
  4. Minor Primary completion date: Mar 2026 to Oct 1, 2025
    • Study completion date: Mar 2026 to Feb 28, 2026
    v7
  5. Notable Start date: Sep 15, 2022 to Jul 1, 2023v6
Show 4 earlier versionsHide 4 earlier versions
  1. Minor Re-verified, no change to tracked fieldsv5
  2. Notable Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Study sites: 0 to 1
    v4
  3. Notable Start date: Jun 15, 2022 to Sep 15, 2022v3
  4. Notable Primary endpoints revised (2)
    • Study description expanded, about 1 word
    v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
38 trials monitored
See 2 trials at risk
Emerging adults (ages 18-25) are at higher risk for substance use disorders, including opiate addiction, than any other age group but are also more likely to drop out early from substance use treatment services. This project will evaluate an enhancement to usual services, delivered by peer recovery supports, specifically aimed at improving treatment adherence and reducing dropout in this age group. The study will also answer key questions about risk factors for dropout among emerging adults and the financial sustainability of enhancing services to reduce dropout.
Trial Details
NCT Number NCT05374395
Lead Sponsor UConn Health
Collaborators: Oregon Social Learning Center, University of Texas at Austin
Conditions
(from sponsor)
Substance Use Disorders
Related terms Substance-Related Disorders
Enrollment 11 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov